Dive in

We have our own point of view on the people, technologies, and conversations that will shape the future.

Tag results
Generative Ai
Clear all
List view Grid view
Filters

Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference​

For those in healthcare, JPM provides the unofficial kickoff to every new year with a chance to recap the year before and inform our view on the year ahead.

AI for Security: Eight Areas of Opportunity
Security for AI: The New Wave of Startups Racing to Secure the AI Stack
The Modern AI Stack: Design Principles for the Future of Enterprise AI Architectures
2023: The State of Generative AI in the Enterprise
Hardening the Data Moat: Our Investment in Cleanlab

Our Investment in Vilya: AI-Enabled Development of a New Class of Medicines

Predictive and generative AI are entering many new applications. At Menlo Ventures, we are especially excited about applications for AI in drug discovery and development, specifically when new technology can directly address a major unmet need.

Opportunities and Challenges of Applying Generative AI to Designing New Drugs

Drug design is both a natural fit and a unique challenge for generative AI, given large but messy datasets, time and cost of real-world testing, and the complexity of human trials.

Generative AI: Lessons From Prior Waves
Our Investment in Anthropic: The Foundation Layer for Generative AI
Video: Engineering New Drugs With Generative AI at Genesis Therapeutics
The Seven Generative AI Building Blocks for the Next Generation of Consumer Technology Companies

Pinecone Now Valued at $750M, Arguably the Most Important Element in the Modern Data Stack

Pinecone has raised a $100M Series B led by A16Z—with explosive growth justifying their new $750M valuation.

Our Investment in Typeface: Generative AI at Enterprise Speed and Scale
Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference​

For those in healthcare, JPM provides the unofficial kickoff to every new year with a chance to recap the year before and inform our view on the year ahead.

February 13, 2024Greg Yap, Johnny Hu and Ph.D.
AI for Security: Eight Areas of Opportunity

Generative AI is a powerful technology in the hands of both good and bad actors. While cybercriminals can use GenAI to complicate and expand existing threats, it’s also an incredible defensive technology.

February 8, 2024Venky Ganesan, Rama Sekhar, Feyza Haskaraman and Sam Borja
Security for AI: The New Wave of Startups Racing to Secure the AI Stack

In the race to adopt generative AI, every enterprise grapples with a common concern: security.

February 6, 2024Venky Ganesan, Rama Sekhar, Feyza Haskaraman and Sam Borja
The Modern AI Stack: Design Principles for the Future of Enterprise AI Architectures

The future of the modern AI stack is being decided now. More than ever, machines are capable of reasoning, creation, and creativity, and these new capabilities are driving enterprises to reconstruct their tech stacks.

January 18, 2024Matt Murphy, Tim Tully, Grace Ge, Derek Xiao and Katie Keller
2023: The State of Generative AI in the Enterprise

Menlo Ventures surveyed more than 450 enterprise executives to provide a view into generative AI adoption in the enterprise today.

November 10, 2023Naomi Pilosof Ionita and Derek Xiao
Hardening the Data Moat: Our Investment in Cleanlab

With Cleanlab, AI teams automate weeks of manual data labeling and bypass dozens of engineering hours for model training and deployment.

October 10, 2023Matt Murphy, Katie Keller and Grace Ge
Our Investment in Vilya: AI-Enabled Development of a New Class of Medicines

Predictive and generative AI are entering many new applications. At Menlo Ventures, we are especially excited about applications for AI in drug discovery and development, specifically when new technology can directly address a major unmet need.

September 15, 2023Johnny Hu, Ph.D. and Greg Yap
Opportunities and Challenges of Applying Generative AI to Designing New Drugs

Drug design is both a natural fit and a unique challenge for generative AI, given large but messy datasets, time and cost of real-world testing, and the complexity of human trials.

August 9, 2023Johnny Hu and Ph.D.
Generative AI: Lessons From Prior Waves

While navigating this exciting yet complex landscape may seem daunting for startups, lessons from past tech waves, along with a thoughtful, strategic approach, can help illuminate the path forward.

May 31, 2023Steve Sloane
Our Investment in Anthropic: The Foundation Layer for Generative AI

We stand on the precipice of an extraordinary platform shift catalyzed by groundbreaking advancements in generative artificial intelligence.

May 23, 2023Matt Murphy, Derek Xiao and Andreas Vandris
Video: Engineering New Drugs With Generative AI at Genesis Therapeutics

Genesis Therapeutics is pioneering AI technologies to create medicines for patients with severe and unmet medical needs.

May 2, 2023Greg Yap
The Seven Generative AI Building Blocks for the Next Generation of Consumer Technology Companies

OpenAI’s ChatGPT reached 100 million monthly active users just two months after launch, setting the new standard for the fastest-growing consumer application in history. The landmark achievement underscored the strength of generative AI’s pull in consumer markets—surpassing even the breakthroughs of the internet and smartphones.

April 27, 2023Shawn Carolan, Katie Keller and Derek Xiao
Pinecone Now Valued at $750M, Arguably the Most Important Element in the Modern Data Stack

Pinecone has raised a $100M Series B led by A16Z—with explosive growth justifying their new $750M valuation.

April 27, 2023Tim Tully
Our Investment in Typeface: Generative AI at Enterprise Speed and Scale

Since the advent of the internet, few technological advances have garnered as much attention and enthusiasm as quickly as generative AI.

February 27, 2023Matt Murphy and Derek Xiao
loader.svg